• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Bausch + Lomb

Bausch + Lomb, Clearside Biomedical launch Xipere in U.S.

March 28, 2022 By Sean Whooley

Bausch Health’s (NYSE:BHC) Bausch + Lomb and Clearside Biomedical (Nasdaq:CLSD) launched their Xipere product in the U.S. today. Clearside Biomedical designed the Xipere triamcinolone acetonide suprachoroidal injectable suspension therapy with a proposed indication for treating macular edema associated with uveitis, a form of eye inflammation. Xipere works with Clearside’s proprietary SCS Microinjector to deliver the therapy to […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Optical/Ophthalmic, Pharmaceutical Tagged With: Bausch + Lomb, bauschhealth, Clearside Biomedical

FDA approves Bausch + Lomb dispersive ophthalmic viscosurgical device

April 7, 2021 By Sean Whooley

Bausch + Lomb announced today that it received FDA approval for its ClearVisc dispersive ophthalmic viscosurgical device (OVD). Laval, Quebec–based Bausch + Lomb — the eye health business unit of Bausch Health — developed the ClearVisc OVD for use in ophthalmic surgery to aid in cataract extraction and intraocular lens (IOL) implantation through the creation […]

Filed Under: Food & Drug Administration (FDA), Optical/Ophthalmic, Regulatory/Compliance, Surgical Tagged With: Bausch + Lomb, bauschhealth, FDA

Bausch + Lomb wins FDA 510(k) for contact lens coating

February 13, 2019 By Fink Densford

Bausch + Lomb said today that it won FDA 510(k) clearance for the use of Tangible Hydra-PEG contact lens coating on new devices, now cleared for use with lenses made from its Boston gas permeable materials. The new clearance will allow the Bridgewater, N.J.-based company to use the coating on its Boston XO, Boston XO2, […]

Filed Under: 510(k), Food & Drug Administration (FDA), Optical/Ophthalmic, Regulatory/Compliance Tagged With: Bausch + Lomb

Analyst downgrades pressure medtech stocks

January 3, 2019 By Brad Perriello

Several medical device companies took hits yesterday after analysts on Wall Street downgraded their stocks, on a day when the major market indices each closed up a hair, and even medtech firms that enjoyed upgrades came under pressure. Globus Medical (NYSE:GMED) suffered the most after Morgan Stanley analyst David Lewis cut his rating on the stock from […]

Filed Under: Featured, Wall Street Beat Tagged With: Abbott, Apollo Endosurgery, Bausch + Lomb, Baxter, Bayer, Globus Medical, Henry Schein Inc., Hologic, Insulet, Medtronic, Smith & Nephew, Stryker, Tactile Systems Technology, Zimmer Biomet

Systemic therapy beats Bausch & Lomb implant in NIH uveitis study

May 8, 2017 By Sarah Faulkner

Systemic therapy of corticosteroids and immunosuppressants better preserved vision in patients with uveitis compared to Bausch & Lomb‘s long-lasting corticosteroid intraocular implant in a clinical trial supported by the National Eye Institute, a branch of the National Institutes of Health. In 7 years, visual acuity remained stable in patients receiving systemic therapy and declined by […]

Filed Under: Clinical Trials, Drug-Device Combinations, Implants, Optical/Ophthalmic, Pharmaceutical, Wall Street Beat Tagged With: Bausch + Lomb, National Institutes of Health (NIH)

Bausch & Lomb wins FDA 510(k) for Vitesse open-port vitrectomy system

April 27, 2017 By Fink Densford

Valeant Pharmaceuticals (NYSE:VRX, TSE:VRX) subsidiary Bausch & Lomb said today it won FDA 510(k) clearance for its Vitesse hypersonic open port vitrectomy system. The Bridgewater, N.J.-based company touted the newly cleared system as the 1st and only hypersonic 100% open port vitrectomy system, and said it will be exclusively available on the Stellaris Elite vision enhancement […]

Filed Under: 510(k), Food & Drug Administration (FDA), Optical/Ophthalmic, Regulatory/Compliance Tagged With: Bausch + Lomb, Valeant Pharmaceuticals

Sanofi promotes Sibold to exec VP of Sanofi Genzyme | Personnel Moves – April 13, 2017

April 17, 2017 By Sarah Faulkner

Sanofi (NYSE:SNY) said at the start of April that it promoted Bill Sibold to exec VP of Sanofi Genzyme, effective July 1, 2017. Sibold succeeds Dr. David Meeker, who is slated to leave the company at the end of June. Sibold is the head of Sanofi Genzyme’s global multiple sclerosis, oncology and immunology organization. He […]

Filed Under: Pharmaceutical, Wall Street Beat Tagged With: Bausch + Lomb, GlucoMe, Mylan, Pulmatrix Inc., Sanofi-Aventis

FDA clears Bausch & Lomb’s Stellaris Elite cataract system

April 6, 2017 By Fink Densford

Valeant Pharmaceuticals (NYSE:VRX, TSE:VRX) subsidiary Bausch & Lomb said today it won FDA 510(k) clearance for its Stellaris Elite vision enhancement system. The system is a next-gen phacoemulsification cataract platform designed for cataract lens removal, and offers improved customization and precise aspiration control with predictive infusion management, Bausch & Lomb said. “We are pleased to continue […]

Filed Under: 510(k), Food & Drug Administration (FDA), Optical/Ophthalmic, Regulatory/Compliance Tagged With: Bausch + Lomb, Valeant Pharmaceuticals

Haemonetics taps ex-Medtronic CIO Burke as new CFO | Personnel Moves August 4, 2016

August 4, 2016 By Fink Densford

Haemonetics taps ex-Medtronic CIO Burke as new CFO   Haemonetics (NYSE:HAE) said this week it tapped former Medtronic (NYSE:MDT) chief integration officer William Burke as its new chief financial officer, effective August 8. Burker operated as CIO with Medtronic since 2015, serving during the integration of Covidien. Prior to that, he held various finance positions with […]

Pages: Page 1 Page 2 Page 3 Page 4 Page 5

Filed Under: Business/Financial News Tagged With: Bausch + Lomb, Covidien, Danaher Corp., Haemonetics, LivaNova, Medtronic, Pavmed, Personnel Moves, Radiology Protocols, ReVision Optics Inc., Zimmer Biomet

Inside Valeant’s ambitious plan for its contact lens business

October 30, 2015 By Brad Perriello

(Reuters) — Valeant Pharmaceuticals (NYSE:VRX, TSE:VRX) has pursued a plan in recent months to dominate the market for specialty contact lenses, according to 2 people familiar with the company’s approach and some of the company’s communications with its customers. The Canadian drugmaker’s goal, spelled out to key employees and demonstrated through its actions, has been to acquire […]

Filed Under: Optical/Ophthalmic, Wall Street Beat Tagged With: Bausch + Lomb, Valeant Pharmaceuticals

Justice Dept., FTC probe Valeant’s Bausch & Lomb, Paragon lens operations

October 27, 2015 By Brad Perriello

The U.S. Justice Dept. and the Federal Trade Commission are investigating Valeant Pharmaceuticals (NYSE:VRX, TSE:VRX) subsidiaries Bausch & Lomb and Paragon Vision Sciences, the Canadian drug maker said yesterday. The Justice Dept. is looking into payments Bausch & Lomb made to doctors using its Crystalens intra-ocular lens and Victus eye laser, Valeant said yesterday in a regulatory […]

Filed Under: Legal News, Optical/Ophthalmic Tagged With: Bausch + Lomb, Federal Trade Commission (FTC), Paragon Vision Sciences, U.S. Justice Dept. (DOJ), Valeant Pharmaceuticals

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS